Literature DB >> 12121614

Apoptosis protection by the Epo target Bcl-X(L) allows factor-independent differentiation of primary erythroblasts.

Helmut Dolznig1, Bianca Habermann, Katharina Stangl, Eva Maria Deiner, Richard Moriggl, Hartmut Beug, Ernst W Müllner.   

Abstract

BACKGROUND: Erythropoietin (Epo) is required for correct execution of the erythroid differentiation program. Erythropoiesis requires Bcl-X(L), a major late target of Epo-receptor signaling. Mice lacking Bcl-X(L) die around embryonic age E12.5, forming normal erythroid progenitors but lacking functional red cells. Recently, serum-free culture conditions for expansion of murine red cell progenitors were developed, yielding cells capable of in vivo-like terminal differentiation into enucleated erythrocytes, in response to Epo/insulin. Here we address whether Epo function during terminal maturation involves a cytokine-independent "default program," requiring only apoptosis inhibition through Epo-dependent upregulation of Bcl-X(L).
RESULTS: Exogenous expression of Bcl-X(L) or Bcl-2 in primary murine erythroblasts or clonal erythroblast lines derived from p53(-/-) mice allowed these cells to undergo terminal erythroid maturation, in the complete absence of cytokines. A potential autocrine Epo loop was ruled out by respective neutralizing antibodies. Importantly, sustained proliferation of Bcl-X(L)-expressing immature erythroblasts still required respective factors (Epo, stem cell factor [SCF], and the glucocorticoid receptor ligand dexamethasone [Dex]). Epo-independent differentiation in these Bcl-X(L)- or Bcl-2-expressing, primary erythroblasts was thus triggered by removal of the renewal factors SCF and Dex. This initiated the maturation-specific expression cascade of erythroid transcription factors, followed by differentiation divisions (characterized by a short G1 phase and decrease in cell size), hemoglobin accumulation, and enucleation.
CONCLUSIONS: During erythroid maturation, Epo regulates red cell numbers via apoptosis inhibition, caused by Epo-dependent upregulation of the antiapoptotic protein Bcl-X(L). This allows "default" terminal differentiation of apoptosis-protected, committed erythroblasts, independent of any exogenous signals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121614     DOI: 10.1016/s0960-9822(02)00930-2

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  43 in total

1.  Cholesterol synthesis-related enzyme oxidosqualene cyclase is required to maintain self-renewal in primary erythroid progenitors.

Authors:  C Mejia-Pous; F Damiola; O Gandrillon
Journal:  Cell Prolif       Date:  2011-10       Impact factor: 6.831

2.  Erythropoietin-mediated expression of placenta growth factor is regulated via activation of hypoxia-inducible factor-1α and post-transcriptionally by miR-214 in sickle cell disease.

Authors:  Caryn S Gonsalves; Chen Li; Marthe-Sandrine Eiymo Mwa Mpollo; Vinod Pullarkat; Punam Malik; Stanley M Tahara; Vijay K Kalra
Journal:  Biochem J       Date:  2015-04-16       Impact factor: 3.857

3.  Critical roles for c-Myb in lymphoid priming and early B-cell development.

Authors:  Kylie T Greig; Carolyn A de Graaf; James M Murphy; Marina R Carpinelli; Swee Heng Milon Pang; Jon Frampton; Benjamin T Kile; Douglas J Hilton; Stephen L Nutt
Journal:  Blood       Date:  2010-02-03       Impact factor: 22.113

4.  BCL2L1 is associated with γ-globin gene expression.

Authors:  Yan Dai; Elmutaz M Shaikho; Jessica Perez; Carolyn A Wilson; Lesley Y Liu; Mitchell R White; John J Farrell; David H K Chui; Paola Sebastiani; Martin H Steinberg
Journal:  Blood Adv       Date:  2019-10-22

5.  The DNA binding factor Hmg20b is a repressor of erythroid differentiation.

Authors:  Fatemehsadat Esteghamat; Thamar Bryn van Dijk; Harald Braun; Sylvia Dekker; Reinier van der Linden; Jun Hou; Pavlos Fanis; Jeroen Demmers; Wilfred van IJcken; Zeliha Ozgür; Rastislav Horos; Farzin Pourfarzad; Marieke von Lindern; Sjaak Philipsen
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

6.  Transcription elongation factor S-II is required for definitive hematopoiesis.

Authors:  Takahiro Ito; Nagisa Arimitsu; Masaki Takeuchi; Nobuyuki Kawamura; Makiko Nagata; Kayoko Saso; Nobuyoshi Akimitsu; Hiroshi Hamamoto; Shunji Natori; Atsushi Miyajima; Kazuhisa Sekimizu
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

7.  Epidermal growth factor triggers an original, caspase-independent pituitary cell death with heterogeneous phenotype.

Authors:  Joanna Fombonne; Stéphanie Reix; Ramahefarizo Rasolonjanahary; Emmanuelle Danty; Sylvie Thirion; Geneviéve Laforge-Anglade; Olivier Bosler; Patrick Mehlen; Alain Enjalbert; Slavica Krantic
Journal:  Mol Biol Cell       Date:  2004-08-25       Impact factor: 4.138

8.  A key commitment step in erythropoiesis is synchronized with the cell cycle clock through mutual inhibition between PU.1 and S-phase progression.

Authors:  Ramona Pop; Jeffrey R Shearstone; Qichang Shen; Ying Liu; Kelly Hallstrom; Miroslav Koulnis; Joost Gribnau; Merav Socolovsky
Journal:  PLoS Biol       Date:  2010-09-21       Impact factor: 8.029

9.  Studying the enucleation process, DNA breakdown and telomerase activity of the K562 cell lines during erythroid differentiation in vitro.

Authors:  Abdolkhaleg Deezagi; Mahkameh Abedi-Tashi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-01-04       Impact factor: 2.416

10.  Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2.

Authors:  Florian Grebien; Marc A Kerenyi; Boris Kovacic; Thomas Kolbe; Verena Becker; Helmut Dolznig; Klaus Pfeffer; Ursula Klingmüller; Mathias Müller; Hartmut Beug; Ernst W Müllner; Richard Moriggl
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.